Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197164) titled 'Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Condition:
COVID - 19
Renal Transplant
SARS CoV 2 Infection
Intervention:
Drug: Remdesivir (RDV)
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: September 1, 2025
Target S...